Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market
Straits Research, a leading provider of business intelligence and market research reports, has announced the release of its latest report on the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market. The report provides an in-depth analysis of the market size, growth, trends, and forecast for the period 2025-2033.
According to the report, the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market size was valued at USD 200.9 billion in 2024 and is projected to reach from USD 214.69 billion in 2025 to USD 378.94 billion in 2033, growing at a CAGR of 6.8% during the forecast period (2025–2033).
Request a free request sample
The report highlights the key drivers, restraints, and opportunities in the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market. The increasing demand for pharmaceutical outsourcing services, the rise of biologics and biosimilars, and the need for cost-effective and efficient manufacturing processes are some of the key factors driving the growth of the market.
The report also provides a comprehensive analysis of the competitive landscape of the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market. Some of the top players operating in the market include:
- Thermo Fisher Scientific, Inc.
- Lonza Group
- WuXi Apptec
- WuXi Biologics
- AbbVie, Inc.
- Catalent, Inc.
- Samsung Biologics
- Evonik Industries AG
- FUJIFILM Holding Corporation
- Siegfried Holding AG
- Boehringer Ingelheim International
- Merck KGaA
- Almac Group
- Charles River Laboratories
- Asychem Inc.
This Report is available for purchase on @
The report provides a detailed segmentation analysis of the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market based on service type, research phase, and end-user. The service type segment is further divided into drug development services, pharmaceutical manufacturing services, biologics manufacturing services, packaging & labelling services, fill-finish services, and others.
The research phase segment is divided into pre-clinical, phase I, phase II, phase III, and phase IV. The end-user segment is divided into big pharmaceutical companies, small & mid-sized pharmaceutical companies, generic pharmaceutical companies, and others.
Straits Research is a leading provider of business intelligence, specializing in research, analytics, and advisory services. The company's reports provide actionable insights and market intelligence to help businesses make informed decisions.
For more information about the report, please contact:
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
Address: 825 3rd Avenue, New York, NY, USA, 10022
Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK)
